Selected article for: "immune system and machine learning"

Author: Amin, Md Shahnoor; Wozniak, Marcin; Barbaric, Lidija; Pickard, Shanel; Yerrabelli, Rahul S.; Christensen, Anton; Coiado, Olivia C.
Title: Experimental Technologies in the Diagnosis and Treatment of COVID-19 in Patients with Comorbidities
  • Cord-id: yc8ev0fd
  • Document date: 2021_9_15
  • ID: yc8ev0fd
    Snippet: The COVID-19 pandemic has impacted the whole world and raised concerns about its effects on different human organ systems. Early detection of COVID-19 may significantly increase the rate of survival; thus, it is critical that the disease is detected early. Emerging technologies have been used to prevent, diagnose, and manage COVID-19 among the populace in the USA and globally. Numerous studies have revealed the growing implementation of novel engineered systems during the intervention at various
    Document: The COVID-19 pandemic has impacted the whole world and raised concerns about its effects on different human organ systems. Early detection of COVID-19 may significantly increase the rate of survival; thus, it is critical that the disease is detected early. Emerging technologies have been used to prevent, diagnose, and manage COVID-19 among the populace in the USA and globally. Numerous studies have revealed the growing implementation of novel engineered systems during the intervention at various points of the disease’s pathogenesis, especially as it relates to comorbidities and complications related to cardiovascular and respiratory organ systems. In this review, we provide a succinct, but extensive, review of the pathogenesis of COVID-19, particularly as it relates to angiotensin-converting enzyme 2 (ACE2) as a viral entry point. This is followed by a comprehensive analysis of cardiovascular and respiratory comorbidities of COVID-19 and novel technologies that are used to diagnose and manage hospitalized patients. Continuous cardiorespiratory monitoring systems, novel machine learning algorithms for rapidly triaging patients, various imaging modalities, wearable immunosensors, hotspot tracking systems, and other emerging technologies are reviewed. COVID-19 effects on the immune system, associated inflammatory biomarkers, and innovative therapies are also assessed. Finally, with emphasis on the impact of wearable and non-wearable systems, this review highlights future technologies that could help diagnose, monitor, and mitigate disease progression. Technologies that account for an individual’s health conditions, comorbidities, and even socioeconomic factors can drastically reduce the high mortality seen among many COVID-19 patients, primarily via disease prevention, early detection, and pertinent management.

    Search related documents:
    Co phrase search for related documents
    • aberrant immune function and acute sars cov respiratory syndrome coronavirus: 1, 2
    • abnormal electrocardiogram and acute respiratory sars cov syndrome coronavirus: 1, 2
    • abnormal electrocardiogram and acute sars cov respiratory syndrome coronavirus: 1, 2
    • abnormal response and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • abnormal response and acute myocarditis: 1, 2
    • abnormal response and acute respiratory sars cov syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8
    • abnormal response and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8
    • abnormal result and ace activity: 1
    • abnormal result and ace inhibitor: 1
    • abnormal result and acute ards respiratory distress syndrome: 1
    • abnormal result and acute respiratory sars cov syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7
    • abnormal result and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7
    • ace activity and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • ace activity and acute cardiac injury: 1
    • ace activity and acute respiratory sars cov syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • ace activity and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • ace inhibitor and acute cardiac injury: 1, 2
    • ace inhibitor and acute myocarditis: 1